UC San Diego researchers used teleoperated humanoid robots to complete two preclinical surgeries, including a robot-assisted gallbladder removal.

A germline‑targeting HIV vaccine produced broadly neutralizing antibodies in about 44% of vaccinated primates, researchers report. The Nature study is a proof‑of‑principle but not proof of protection.

Vertex will buy Crinetics for about $10 billion, adding an FDA‑approved oral acromegaly drug and a late‑stage CAH candidate. The deal is expected to close in Q3 2026.

UC San Diego researchers mapped acetylcholine receptor defects and identified drug targets and a repurposing candidate that could be matched to patients' genes.

Scripps Clinic cardiologist Curtiss Stinis performed San Diego’s first implant of the FDA‑approved Trilogy valve, a new transcatheter option for severe aortic regurgitation.

A global biotech convention has crowded downtown San Diego this week as thousands of researchers, investors and companies converge for panels, partner meetings and exhibits.

Qualcomm is reportedly close to buying AI startup Modular for about $4 billion. The deal would pair chip ambitions with software that runs models across many accelerators.

San Diego’s cAMPfield closed a $180M Series A to advance prifemilast, a once‑daily oral PDE4B inhibitor, into global trials for IBD.

Biogen agreed to buy San Diego‑based RayThera for up to $1 billion, adding early‑stage immunology candidates and a lead program heading into Phase 1.

UC San Diego’s Moores Cancer Center won a five‑year NCI core grant renewal — roughly $25M — to speed trials, hire physicians and expand infusion capacity across San Diego.

A Parkfield study using machine learning found short slow‑slip events that boost low‑frequency quakes, prompting scientists to rethink how California's hazard models account for transient stress.

UC San Diego and Stanford researchers found brief electrical pulses rejuvenated sea squirts and raised questions about stem‑cell aging in people.

Tempo is setting up its corporate headquarters in San Diego as it pushes to commercialize thermochemical “thermal battery” systems for industrial electrification. The move is meant to speed pilots into commercial deployments.